Omar, M.R. et al. 2022. DOSE UP-TITRATION OF EMPAGLIFLOZIN AMONG TYPE 2 DM PATIENTS UNCONTROLLED ON EXISTING ORAL ANTIDIABETIC AGENTS. Journal of the ASEAN Federation of Endocrine Societies. 37, (Jul. 2022), 41–42.